Abstract
Purpose of Review
Spinal cord stimulation (SCS) has been used for decades to alleviate chronic pain. A growing body of literature suggests that the procedure is not without risks. Understanding the risks of SCS implantation can help treating physicians formulate individualized care plans that promote patient safety and minimize risks.
Recent Findings
The overall complication rate associated with SCS has been reported to be 31.9 to 43%. The most common complication in the literature appears to be electrode migration. Other complications ranging in rates of occurrence include hematoma formation, infection, spinal cord injury, and cerebrospinal fluid (CSF) leak. Case reports of syrinx formation, foreign body reaction, and fibrosis have also been described.
Summary
Our review shows that there are strategies available to reduce and prevent complications. In addition, close monitoring and early intervention may prevent some of the adverse neurological outcomes. Nevertheless, additional research regarding patient and procedural factors is necessary to improve the safety profile of this intervention.
Similar content being viewed by others
References
Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150(3699):971–9.
Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg. 1967;46(4):489–91.
Manchikanti L, et al. Spinal cord stimulation trends of utilization and expenditures in fee-for-service (FFS) Medicare population from 2009 to 2018. Pain Physician. 2021;24(5):293–308.
Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: A 20-year literature review. J Neurosurg. 2004;100(3 Suppl Spine):254–67.
Kumar K, Bishop S. Financial impact of spinal cord stimulation on the healthcare budget: a comparative analysis of costs in Canada and the United States. J Neurosurg Spine. 2009;10(6):564–73.
Kumar K, et al. Complications of spinal cord stimulation, suggestions to improve outcome, and financial impact. J Neurosurg Spine. 2006;5(3):191–203.
Taylor RS, Van Buyten JP, Buchser E. Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors. Spine (Phila Pa 1976). 2005;30(1):152–60.
North RB, et al. Prevention of percutaneous spinal cord stimulation electrode migration: a 15-year experience. Neuromodulation. 2014;17(7):670–6; discussion 676–7.
Dombovy-Johnson ML, et al. Incidence and risk factors for spinal cord stimulator lead migration with or without loss of efficacy: a retrospective review of 91 consecutive thoracic lead implants. Neuromodulation. 2022;25(5):731–7.
West T, et al. Incidence of lead migration with loss of efficacy or paresthesia coverage after spinal cord stimulator implantation: systematic review and proportional meta-analysis of prospective studies and randomized clinical trials. Neuromodulation. 2023.
Gupta M, et al. A retrospective review of lead migration rate in patients permanently implanted with percutaneous leads and a 10 kHz SCS device. Pain Res Manag. 2021;2021:6639801.
Hayek SM, Veizi E, Hanes M. Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of eight years of experience from an academic center database. Neuromodulation. 2015;18(7):603–8; discussion 608–9.
Geurts JW, et al. Spinal cord stimulation for complex regional pain syndrome type I: a prospective cohort study with long-term follow-up. Neuromodulation. 2013;16(6):523–9; discussion 529.
Eldabe S, Buchser E, Duarte RV. Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature. Pain Med. 2016;17(2):325–36.
Buvanendran A, Young AC. Spinal epidural hematoma after spinal cord stimulator trial lead placement in a patient taking aspirin. Reg Anesth Pain Med. 2014;39(1):70–2.
West T, Driver CN, D'Souza RS. Incidence of neuraxial and non-neuraxial hematoma complications from spinal cord stimulator surgery: systematic review and proportional meta-analysis. Neuromodulation. 2022.
Antithrombotic Trialists C, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–60.
Oscarsson A, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104(3):305–12.
Burger W, et al. Low-dose aspirin for secondary cardiovascular prevention - Cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - Review and meta-analysis. J Intern Med. 2005;257(5):399–414.
Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004;62(7):1187–9.
Deer TR, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): Recommendations on bleeding and coagulation management in neurostimulation devices. Neuromodulation. 2017;20(1):51–62.
Moeschler SM, et al. Bleeding complications in patients undergoing percutaneous spinal cord stimulator trials and implantations. Pain Med. 2016;17(11):2076–81.
Leese PT, et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol. 2000;40(2):124–32.
Hussain N, et al. Evaluating the incidence of spinal cord injury after spinal cord stimulator implant: an updated retrospective review. Reg Anesth Pain Med. 2022;47(7):401–7.
Lee LO, et al. Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the multicenter perioperative outcomes group. Anesthesiology. 2017;126(6):1053–63.
Bauer ME, et al. The Society for Obstetric Anesthesia and Perinatology interdisciplinary consensus statement on neuraxial procedures in obstetric patients with thrombocytopenia. Anesth Analg. 2021;132(6):1531–44.
Richardson RR, Nunez C, Siqueira EB. Histological reaction to percutaneous epidural neurostimulation: initial and long-term results. Med Prog Technol. 1979;6(4):179–84.
Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery. 2006;58(3):481–96; discussion 481–96.
Kiss ZH, Dostrovsky JO, Tasker RR. Plasticity in human somatosensory thalamus as a result of deafferentation. Stereotact Funct Neurosurg. 1994;62(1–4):153–63.
Arle JE, et al. Modeling effects of scar on patterns of dorsal column stimulation. Neuromodulation. 2014;17(4):320–33; discussion 333.
Reynolds AF, Shetter AG. Scarring around cervical epidural stimulating electrode. Neurosurgery. 1983;13(1):63–5.
Al Tamimi M, Aoun SG, Gluf W. Spinal cord compression secondary to epidural fibrosis associated with percutaneously placed spinal cord stimulation electrodes: case report and review of the literature. World Neurosurg. 2017;104:1051.e1–1051.e5.
Cicuendez M, et al. Dorsal myelopathy secondary to epidural fibrous scar tissue around a spinal cord stimulation electrode. J Neurosurg Spine. 2012;17(6):598–601.
Dam-Hieu P, et al. Cervical cord compression due to delayed scarring around epidural electrodes used in spinal cord stimulation. J Neurosurg Spine. 2010;12(4):409–12.
Guzzi G, et al. Cervical spinal cord compression from delayed epidural scar tissue formation around plate lead for SCS. J Neurosurg Sci. 2019;63(3):337–43.
Lennarson PJ, Guillen FT. Spinal cord compression from a foreign body reaction to spinal cord stimulation: a previously unreported complication. Spine (Phila Pa 1976). 2010;35(25):E1516–9.
Villavicencio AT, et al. Laminectomy versus percutaneous electrode placement for spinal cord stimulation. Neurosurgery. 2000;46(2):399–405; discussion 405–6.
Wada E, Kawai H. Late onset cervical myelopathy secondary to fibrous scar tissue formation around the spinal cord stimulation electrode. Spinal Cord. 2010;48(8):646–8.
Fransen P. Reversible late thoracic myelopathy and neurostimulation tolerance caused by fibrous scar tissue formation around the spinal cord stimulation electrode. Neuromodulation. 2015;18(8):759–61.
Ali SS, et al. Spinal cord stimulator explant and revision complicated by syrinx formation: a case report and literature review. Cureus. 2019;11(8):e5299.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Garg, I., Wang, D. Complications of Spinal Cord Stimulator Trials and Implants: A Review. Curr Pain Headache Rep 27, 837–842 (2023). https://doi.org/10.1007/s11916-023-01190-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-023-01190-7